Results 81 to 90 of about 18,482 (120)

Fabrication of Yy‐Pr1‐y ‐Ba‐Cu‐O Thin Films and Superlattices of ‐Ba‐Cu‐O/Yy‐Pr1‐y ‐Ba‐Cu‐O

open access: yes, 1989
We have prepared epitaxial thin films of Yy‐Pr1‐y‐Ba‐Cu‐O (y= 1 to 0) and superlattices of Y‐Ba‐Cu‐O/Yy‐Pr1‐y ‐Ba‐Cu‐O using pulsed laser deposition technique. The zero resistance transition temperatures of Yy‐Pr1‐y‐Ba‐Cu‐O bulk samples are reproduced in
Martinez, JA   +12 more
core  

Polarization ray picture of coherence for vectorial electromagnetic waves

open access: yes, 2007
© 2007 Optical Society of America. I thank I. Gonzalo for a critical reading of the manuscript and valuable suggestions. This work has been supported by Project PR1-A/07-15378 of the Universidad Complutense.We elucidate a ray picture of coherence for ...
Luis Aina, Alfredo
core   +1 more source

Interface double-exchange ferromagnetism in the Mn-Zn-O system: New class of biphase magnetism

open access: yes, 2005
©2005 The American Physical Society. This work has been partially supported by the University Complutense Project No. PR1/05-13325. Partial support from the EU Network of Excellence SANDIE is also acknowledged.In this Letter, we experimentally show that ...
Hernando Grande, Antonio   +4 more
core   +1 more source

A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2 [PDF]

open access: yes, 2019
Despite substantial advances in the treatment of acute myeloid leukemia (AML), only 30% of patients survive more than 5 years. Therefore, new therapeutics are much needed.
Jin S. Im   +27 more
core   +1 more source

PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival

open access: yes, 2007
Background: PR1 peptide has been established as a human myeloid leukemia-associated antigen. We studied PR1 peptide vaccine in a phase I/II clinical trial in HLA-A2 + patients with AML, MDS and CML.
Wang, Xuemei   +12 more
core   +1 more source

The phenotype of PR1-CTL changes from predominantly naïve to memory upon stimulation.

open access: yes, 2013
PBMC from patient 3 were labeled with CFSE, stimulated for 80 hours, then labeled with antibodies for analysis of surface phenotype by FACS to determine naïve (N), central memory (CM), and effector memory (EM) cells, as described in the text.
Gheath Alatrash (210415)   +6 more
core   +1 more source

Термический анализ, тепловое расширение индатов празеодима-лантана Pr1-xLaxInO3 [PDF]

open access: yes, 2012
Впервые керамическим методом синтезированы твердые растворы индатов празеодималантана Pr1–xLaxInO3. Установлено, что в двойной системе PrInO3 – LaInO3 образуется непрерывный ряд твердых растворов состава Pr1–хLaxInO3, обладающих кристаллической ...
Башкиров, Леонид Андреевич   +2 more
core  

DA increases apoptosis in PR1-D2S cells incubated in the presence of E2.

open access: yes, 2013
PR1-V, PR1-D2L or PR1-D2S cells were cultured with DMEM-F12-SS in the absence (A) or presence of E2 (1 nM, B) for 48 h. Then the cells were incubated with DA (1 µM-100 µM) in the presence or absence of E2 for 4 h and apoptosis was detected by ELISA. Each
Daniel Pisera (314728)   +5 more
core   +1 more source

PR1 Leukemia-Associated Antigen Is Cross-Presented by B Cells from Soluble Serum Proteases

open access: yes, 2005
PR1 (VLQELNVTV) is an HLA-A*0201-binding leukemia-associated peptide epitope within proteinase 3 (PRTN3) and neutrophil elastase (ELA2), and PR1-specific CD8+ cytotoxic T lymphocytes (PR1-CTL) contribute to cytogenetic remission in some patients with ...
Wang, Changqing   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy